XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 11.74%17.95B | 14.63%4.92B | 11.81%4.48B | 9.81%4.6B | 10.45%3.95B | 0.37%16.06B | -15.46%4.29B | 2.78%4B | 7.96%4.19B | 13.53%3.58B |
Operating revenue | 11.74%17.95B | 14.63%4.92B | 11.81%4.48B | 9.81%4.6B | 10.45%3.95B | 0.37%16.06B | -15.46%4.29B | 2.78%4B | 7.96%4.19B | 13.53%3.58B |
Cost of revenue | 12.20%12.73B | 17.18%3.57B | 12.56%3.18B | 9.20%3.21B | 9.29%2.78B | 1.55%11.34B | -15.00%3.04B | 4.16%2.82B | 10.34%2.94B | 14.55%2.54B |
Gross profit | 10.63%5.22B | 8.41%1.35B | 10.01%1.3B | 11.24%1.39B | 13.28%1.17B | -2.38%4.72B | -16.56%1.25B | -0.34%1.18B | 2.77%1.25B | 11.09%1.03B |
Operating expense | 0.61%1.33B | -36.28%198.14M | 15.07%409.4M | 14.62%363.64M | 6.18%360.13M | -4.97%1.32B | -12.06%310.94M | 0.83%355.79M | -10.38%317.26M | 2.21%339.19M |
Selling and administrative expenses | 0.66%1.32B | -36.55%195.64M | 15.21%406.9M | 14.78%361.15M | 6.26%357.59M | -4.97%1.31B | -12.12%308.32M | 0.87%353.17M | -10.43%314.64M | 2.28%336.52M |
Depreciation amortization depletion | -4.78%10.03M | -4.77%2.5M | -4.77%2.5M | -4.77%2.5M | -4.87%2.54M | -5.22%10.54M | -5.14%2.62M | -5.17%2.62M | -5.17%2.62M | -5.35%2.67M |
-Depreciation and amortization | -4.78%10.03M | -4.77%2.5M | -4.77%2.5M | -4.77%2.5M | -4.87%2.54M | -5.22%10.54M | -5.14%2.62M | -5.17%2.62M | -5.17%2.62M | -5.35%2.67M |
Operating profit | 14.53%3.89B | 23.22%1.16B | 7.84%891.49M | 10.09%1.03B | 16.74%811.52M | -1.33%3.4B | -17.95%938.62M | -0.84%826.71M | 8.15%935.86M | 16.01%695.12M |
Net non-operating interest income expense | -3.37%59.01M | -43.73%11.09M | -28.96%13.63M | 12.13%17.02M | 147.02%17.26M | 3,519.68%61.06M | 2,205.26%19.71M | 6,189.51%19.18M | 6,647.56%15.18M | 2,214.24%6.99M |
Non-operating interest income | -3.33%59.49M | -43.43%11.22M | -28.78%13.75M | 12.02%17.14M | 144.91%17.38M | 3,021.92%61.53M | 2,048.65%19.83M | 5,117.03%19.3M | 5,176.55%15.3M | 1,728.87%7.1M |
Non-operating interest expense | 2.13%479K | 4.10%127K | 0.00%120K | -2.50%117K | 7.48%115K | 65.14%469K | 79.41%122K | 84.62%120K | 84.62%120K | 24.42%107K |
Other net income (expense) | 803.25%56.98M | 230.97%15.07M | -24.05%1.08M | -51.04%965K | 332,075.00%39.86M | -88.99%-8.1M | -160.49%-11.51M | 106.26%1.42M | 305.96%1.97M | -96.85%12K |
Earnings from equity interest | 869.11%44.2M | 662.44%1.62M | 181.48%2.51M | 129.56%2.17M | 1,408.24%37.9M | -91.00%4.56M | -99.56%213K | 99.78%891K | 30.57%944K | 105.81%2.51M |
Special income (charges) | 19.09%-18.49M | 56.85%-5.86M | -125.98%-4.73M | -157.92%-3.84M | 28.66%-4.05M | 64.05%-22.85M | 56.31%-13.58M | 91.44%-2.09M | 66.91%-1.49M | -61.91%-5.68M |
-Less:Other special charges | 133.48%222K | --0 | ---- | --158K | --64K | ---663K | ---301K | ---362K | ---- | ---- |
-Write off | -22.31%18.27M | -57.79%5.86M | 92.67%4.73M | 147.32%3.69M | -29.79%3.99M | -63.01%23.51M | -55.34%13.88M | -89.96%2.46M | -66.91%1.49M | 61.91%5.68M |
Other non- operating income (expenses) | 206.93%31.26M | 936.90%19.31M | 25.87%3.3M | 4.93%2.64M | 88.97%6.01M | 18.55%10.19M | 2.53%1.86M | 104.60%2.63M | -10.84%2.52M | 19.18%3.18M |
Income before tax | 16.14%4.01B | 24.92%1.18B | 6.95%906.2M | 10.00%1.05B | 23.72%868.64M | 0.28%3.45B | -18.65%946.82M | 4.44%847.31M | 10.23%953.01M | 17.04%702.12M |
Income tax | 8.94%922.62M | 14.27%269.49M | -0.12%208.28M | 2.80%239.18M | 21.08%205.67M | 3.00%846.9M | -16.25%235.83M | 13.74%208.54M | 9.68%232.67M | 17.01%169.86M |
Net income | 18.48%3.08B | 28.45%913.24M | 9.26%697.91M | 12.33%809.13M | 24.56%662.98M | -0.57%2.6B | -19.41%710.99M | 1.73%638.78M | 10.41%720.35M | 17.05%532.26M |
Net income continuous Operations | 18.48%3.08B | 28.45%913.24M | 9.26%697.91M | 12.33%809.13M | 24.56%662.98M | -0.57%2.6B | -19.41%710.99M | 1.73%638.78M | 10.41%720.35M | 17.05%532.26M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 18.48%3.08B | 28.45%913.24M | 9.26%697.91M | 12.33%809.13M | 24.56%662.98M | -0.57%2.6B | -19.41%710.99M | 1.73%638.78M | 10.41%720.35M | 17.05%532.26M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | -41.26%9.5M | -53.42%2.45M | -41.01%2.2M | -36.05%2.49M | -30.65%2.27M | |||||
Net income attributable to common stockholders | 18.91%3.08B | 28.89%913.24M | 9.64%697.91M | 12.71%809.13M | 25.09%662.98M | -0.32%2.59B | -19.21%708.55M | 1.98%636.57M | 10.69%717.86M | 17.40%529.99M |
Basic earnings per share | 25.70%14.82 | 35.45%4.47 | 15.75%3.38 | 19.50%3.86 | 33.19%3.13 | 6.50%11.79 | -14.51%3.3 | 8.15%2.92 | 17.88%3.23 | 27.72%2.35 |
Diluted earnings per share | 25.34%14.69 | 35.06%4.43 | 15.52%3.35 | 19.31%3.83 | 31.91%3.1 | 6.45%11.72 | -14.81%3.28 | 7.81%2.9 | 17.58%3.21 | 28.42%2.35 |
Dividend per share | 20.59%0.82 | 10.00%0.22 | 25.00%0.2 | 25.00%0.2 | 25.00%0.2 | 11.48%0.68 | 25.00%0.2 | 6.67%0.16 | 6.67%0.16 | 6.67%0.16 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |